CD44 and cancer: Except CD44+CD133+ subset and OV6+ subset, we found that HBx upregulated a subset with positive expression of ABCG2, a drug resistance-associated protein, which had been characterized by high expression of cancer stemness-related proteins, including Oct4, Bmi-1, and CD44.